10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31305159 | Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling. | 2020 Feb | 1 |
2 | 32390763 | TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma. | 2020 | 7 |
3 | 32781203 | Tissue-based long non-coding RNAs "PVT1, TUG1 and MEG3" signature predicts Cisplatin resistance in ovarian Cancer. | 2020 Nov | 2 |
4 | 30925453 | lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer. | 2019 Jun 7 | 3 |
5 | 31287493 | LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. | 2019 Aug 5 | 2 |
6 | 31424656 | Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway. | 2019 May-Jun | 3 |
7 | 31532756 | Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition. | 2019 Sep 18 | 1 |
8 | 29543785 | Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma. | 2018 Mar 15 | 1 |
9 | 30098551 | Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer. | 2018 Nov | 4 |
10 | 30519392 | TUG1 confers cisplatin resistance in esophageal squamous cell carcinoma by epigenetically suppressing PDCD4 expression via EZH2. | 2018 | 2 |